Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...
If they pull it off successfully, higher inflation may not be a problem if it results in much more broad-based economic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback